To Compare Safety and Efficacy of Doripenem Versus Imipenem-Cilastatin in Patients With Ventilator-Associated Pneumonia
Clinical trial NCT00589693 · TERMINATED
Trial details
- NCT number
- NCT00589693
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2011-06-01
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.